These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1226 related articles for article (PubMed ID: 27807347)

  • 21. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress of SELEX methods for screening nucleic acid aptamers.
    Zhu C; Feng Z; Qin H; Chen L; Yan M; Li L; Qu F
    Talanta; 2024 Jan; 266(Pt 1):124998. PubMed ID: 37527564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aptamer Technology and Its Applications in Bone Diseases.
    Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
    Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in binder identification and characterisation: the case of oligonucleotide aptamers.
    Taouji S; Dausse E; Evadé L; Di Primo C; Toulmé JJ; Chevet E
    N Biotechnol; 2012 Jun; 29(5):550-4. PubMed ID: 22178698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical Modifications for a Next Generation of Nucleic Acid Aptamers.
    Chan KY; Kinghorn AB; Hollenstein M; Tanner JA
    Chembiochem; 2022 Aug; 23(15):e202200006. PubMed ID: 35416400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-Internalization SELEX of RNA Aptamers as a Starting Point for Prostate Cancer Research.
    Rodríguez-Dorantes M; Cortés-Ramírez SA; Cruz-Burgos JM; Reyes-Grajeda JP; Losada-García A; González-Covarrubias V; Cruz-Hernández CD
    Methods Mol Biol; 2021; 2174():245-254. PubMed ID: 32813254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological applications of xeno nucleic acids.
    Morihiro K; Kasahara Y; Obika S
    Mol Biosyst; 2017 Jan; 13(2):235-245. PubMed ID: 27827481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in aptamer selection methods and applications.
    Yüce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamers in analytics.
    Ilgu M; Nilsen-Hamilton M
    Analyst; 2016 Mar; 141(5):1551-68. PubMed ID: 26864075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Nucleic Acid Aptamer Candidates against a Novel Calicivirus Protein Target.
    Faircloth J; Moore MD; Stoufer S; Kim M; Jaykus LA
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acid pool preparation and characterization.
    Piasecki SK; Hall B; Ellington AD
    Methods Mol Biol; 2009; 535():3-18. PubMed ID: 19377997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for siRNA navigation to desired cells.
    Sioud M
    Methods Mol Biol; 2015; 1218():201-16. PubMed ID: 25319653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
    Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA
    ACS Nano; 2019 Nov; 13(11):12301-12321. PubMed ID: 31664817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamers as drug delivery vehicles.
    Kruspe S; Mittelberger F; Szameit K; Hahn U
    ChemMedChem; 2014 Sep; 9(9):1998-2011. PubMed ID: 25130604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aptamers Chemistry: Chemical Modifications and Conjugation Strategies.
    Odeh F; Nsairat H; Alshaer W; Ismail MA; Esawi E; Qaqish B; Bawab AA; Ismail SI
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.
    Yan AC; Levy M
    Nucleic Acid Ther; 2018 Jun; 28(3):194-199. PubMed ID: 29883295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-specific aptamer-mediated targeted drug delivery.
    Zhou J; Rossi JJ
    Oligonucleotides; 2011 Feb; 21(1):1-10. PubMed ID: 21182455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to manipulate the performance of aptamers in SELEX, post-SELEX and microenvironment.
    Qi S; Duan N; Khan IM; Dong X; Zhang Y; Wu S; Wang Z
    Biotechnol Adv; 2022; 55():107902. PubMed ID: 35026382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.